F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editingnews2023-12-09T02:22:13+00:00December 9th, 2023|The New York Times|
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Mostnews2023-12-08T22:46:17+00:00December 8th, 2023|The New York Times|
Why We’re Stuck in a Constant Cycle of Drug Shortagesnews2023-12-06T14:05:41+00:00December 6th, 2023|The New York Times|
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Upnews2023-12-06T11:59:57+00:00December 6th, 2023|The New York Times|
CVS Says It Will Change the Way Its Pharmacies Are Paidnews2023-12-05T23:27:46+00:00December 5th, 2023|The New York Times|
¿Un medicamento para que tu perro viva más?news2023-11-30T12:44:11+00:00November 30th, 2023|The New York Times|
Congress Must Act to Eliminate Hepatitis Cnews2023-11-29T17:50:00+00:00November 29th, 2023|The New York Times|
Israel-Hamas Truce Appears to Enter Another Day, and Morenews2023-11-28T11:02:10+00:00November 28th, 2023|The New York Times|
Could Longevity Drugs for Dogs Extend Your Pet’s Life?news2023-11-28T05:01:45+00:00November 28th, 2023|The New York Times|
This Quiet Blockbuster at the Supreme Court Could Impact All Americansnews2023-11-22T13:46:34+00:00November 22nd, 2023|The New York Times|
